🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Acute Coronary Syndromes (ACS)

Evaluation Through Innovative Examinations of Intestinal Dysbiosis Status in Patients Diagnosed With Cardiovascular Diseases and Evaluation of the Efficacy of Natural and Probiotic Extracts in the Non-pharmacological Approach to Improving Intestinal Dysbiosis Status. NCT07429227NA1 site📍 Peschiera del Garda Casa di Cura Dott. Pederzoli · Tests: Tea tree (Melaleuca alternifolia), Cinnamon (Cynnamomum zeylanicum) bark, Clove carnation (Eugenia caryopyllus) flowers… Development and Implementation Model of Home Based Cardiac Rehabilitation With Family Empowerment Approach in Patient With ACS (HBCR in ACS) NCT06625463NA2 sites📍 Sleman📍 Yogyakarta Gadjah Mada University · Tests: Home based cardiac rehabilitation Single vs. Dual Antiplatelet Therapy in Patients Undergoing Percutaneous Intervention With DCB-only Strategy (KONG-FREEDOM-I) NCT07587099NA14 sites📍 Beijing📍 Haikou📍 Harbin Gan Lijun · Tests: Drug-coated balloon, Single antiplatelet therapy (SAPT), Dual antiplatelet therapy (DAPT) Analysis of Growth Differentiation Factor 15 (GDF-15), Mid Regional proAdrenomedullin (MR proADM), and Persepsin Levels in Patient in Acute Coronary Syndrome Patients With Pneumonia, With or Without Influenza Vaccination NCT07604103Phase 31 site📍 Malang University of Brawijaya · Tests: Vaxigrip, antibiotic treatments, percutaneus coronary intervention Dual Antithrombotic Therapy With Dabigatran and Ticagrelor in Patients With ACS and Non-valvular AF Undergoing PCI NCT04695106Phase 41 site📍 Gdansk Medical University of Gdansk · Tests: Ticagrelor, Dabigatran Etexilate, Aspirin, Clopidogrel Fexuprazan for Prevention of Upper Gastrointestinal Bleeding in High Bleeding Risk Patients Receiving Dual Antiplatelet Therapy NCT07479056NA1 site📍 Seoul SUK MIN SEO · Tests: Fexuprazan 40mg, Lansoprazole 30mg Influenza Vaccination After Acute Coronary Syndrome NCT07259252NA1 site📍 Wuhan Tongji Hospital · Tests: Influenza vaccine, Placebo Patient-centered Personalized Cardiac Rehabilitation in Post Acute Coronary Syndrome (BREAK-trial) NCT07038265NA1 site📍 L'Hospitalet de Llobregat Institut d'Investigació Biomèdica de Bellvitge · Tests: Personalised treatment, Usual Care MCG for Identification of Myocardial Ischemia in Suspected NSTE-ACS Patients NCT06197724n/a1 site📍 Jinan Qilu Hospital of Shandong University · Tests: Magnetocardiography A Prospective, Single-center, Observational Study Aiming to Assess the Predictive Role of Flow Mediated Dilatation in Acute Coronary Syndromes, Combined With Echocardiographic and Biochemical Indices NCT06890013n/a1 site📍 Thessaloniki Aristotle University Of Thessaloniki · Tests: Observation group Future Optimal Research and Care Evaluation NCT03823547n/a4 sites📍 Apeldoorn📍 Arnhem📍 Ede J.M. ten Berg Drug-Coated Balloon Primary PCI in ST-Segment Elevation Myocardial Infarction NCT07436429n/a1 site📍 Vienna Medical University of Vienna · Tests: Drug-Coated Balloon CCTA Evaluation of SGLT2i-related Pericoronary Fat Changes Patients With Stage 4 CKM Syndrome NCT07351643Phase 41 site📍 Shenyang Shenyang Northern Hospital · Tests: Dapagliflozin Electronic Health Record Augmented LDL-Cholesterol Optimization and Control Via Active Lipid Engagement (EHR-LOCALE): A Quality Improvement Implementation Study NCT07685639NA2 sites📍 Edmonton📍 Edmonton University of Alberta · Tests: Pharmacist-led lipid optimization pathway Ticagrelor With Low-dose Versus Regular Aspirin in Patients With Acute Coronary Syndrome (ACS) at High-Risk for Ischemia After Percutaneous Coronary Intervention NCT04240834Phase 41 site📍 Beijing Fu Wai Hospital, Beijing, China · Tests: Aspirin, Ticagrelor Internet-based Behavioral Intervention Following ACS NCT06298864NA1 site📍 Stockholm Karolinska Institutet · Tests: Internet-CBT, Internet-CL Predictive Value of Glycemic Parameters Measured With the FSL Pro iQ During ACS NCT06014112NA9 sites📍 Béziers📍 Bordeaux📍 Montpellier University Hospital, Montpellier · Tests: Freestyle Libre Pro iQ Multi-omics Characterization and Model Construction of Colchicine Anti-inflammatory Therapy Efficacy in ACS Patients NCT07064109NA1 site📍 Shanghai Shanghai Tongji Hospital, Tongji University School of Medic… · Tests: Colchicine 0.5 MG Oral Tablet Once Daily Artificial Intelligence Based Timing, Infarct Size and Outcomes in Acute Coronary Occlusion Myocardial Infarction NCT06910436n/a1 site📍 Bolzano Azienda Ospedaliera di Bolzano · Tests: Coronary Angiogram Preventive Drug-coated Balloon Angioplasty in Vulnerable Atherosclerotic Plaque (RESTORE Trial) NCT06365502NA18 sites📍 Beijin📍 Zunyi📍 Daqing Harbin Medical University · Tests: Drug-coated balloon, Guideline-directed medical treatment Leave Nothing Behind Study Which Compares DCB With Bail Out BRS Versus BRS Strategy Alone NCT07038408NA1 site📍 Tallinn Ceric Sàrl · Tests: Angioplasty with DCB (bail-out BRS), Angioplasty with BRS Breaking Fasts Ahead of Cardiac Caths NCT06996639NA1 site📍 Tampa University of South Florida · Tests: Non-Fasting, Fasting Effect of Intravenous Iron on Quality of Life in Older Patients With Acute Coronary Syndrome NCT07476859Phase 49 sites📍 El Palmar📍 Vigo📍 Badajoz Fundación para la Investigación del Hospital Clínico de Val… · Tests: Ferric Carboxymaltose Injection [Ferinject] Cangrelor on Top of anticoagUlation in Patients With myocaRdial Infarction-related Cardiogenic Shock/Cardiac Arrest receiVIng VA-ECMO NCT06792643Phase 21 site📍 Milan IRCCS San Raffaele · Tests: Cangrelor Efficacy and Safety Study of Vicagrel in Patients With Acute Coronary Syndrome (ACS) Undergoing Percutaneous Coronary Intervention (PCI) NCT06577519Phase 31 site📍 Shenyang Jiangsu vcare pharmaceutical technology co., LTD · Tests: Vicagrel, Clopidogrel TeleheartCR vs. Clinic-Based Cardiac Rehabilitation After Acute Coronary Syndrome NCT07541014NA1 site📍 New York Columbia University · Tests: Telehealth-enhanced Hybrid CR, Traditional Cardiac Rehabilitation A Clinical Study on the Effect of Cardiopulmonary Function and Quality of Life in Patients With Acute Coronary Syndrome Complicated by Heart Failure by "Lying-Sitting-Standing" Sequential Baduanjin NCT07486791NA1 site📍 Taiyuan Xiling Qi · Tests: standard treatment and routine rehabilitation nursing guidance, "Lying-Sitting-Standing" Sequential Baduanjin Effectiveness of Interventional Therapy for Non-Flow-Limiting Vulnerable Plaques NCT06855537Phase 41 site📍 Beijing Beijing Anzhen Hospital · Tests: PCI strategy, OMT strategy Diagnostic Performance of Artificial Intelligence Algorithms in Prediction of Acute Coronary Syndrome Based on White Blood Cell Properties NCT06384846n/a1 site📍 Graz RobotDreams GmbH CAPRA-EVO: a Randomized Serial PCCT Trial of Early Evolocumab After ACS NCT07612774Phase 42 sites📍 Xi’an📍 Chengdu West China Hospital · Tests: Evolocumab, Serial photon-counting coronary computed tomography angiography, Standard Lipid-Lowering Therapy
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy